IDKOF yields 2.52% · MRK yields 2.76%● Live data
📍 MRK pulled ahead of the other in Year 1
Combined, IDKOF + MRK cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of IDKOF + MRK for your $10,000?
Idemitsu Kosan Co.,Ltd. operates in petroleum, basic chemicals, functional materials, power and renewable energy, and resources businesses in Japan and internationally. The company's Petroleum segment engages in the procurement of crude oil and refining of petroleum products; sale of gasoline, diesel oil, kerosene, automotive lubricants, industrial kerosene, heavy oil, and aviation and marine fuel; and operation of hydrogen stations. Its Basic Chemicals segment manufactures and sells olefins, such as ethylene, propylene, and butadiene; aromatics, including benzene, styrene monomer, mixed xylene, and paraxylene; and other chemicals. The company's Functional Materials segment researches, develops, manufactures, and sells automotive, industrial, and marine lubricants, as well as grease; engineering plastic, adhesive materials, derivative products, and solvents; electronic materials, such as OLED; asphalt; microbial pesticides, soil amendments, and livestock related materials; and solid state lithium ion battery materials. Its Power and Renewable Energy segment operates thermal power plants; develops and operates renewable energy sources, including solar, wind, and biomass power plants; engages in the supply, wholesale, and retail of electric power; researches, develops, and manufactures CIS thin-film solar modules; and sells solar power systems. The company's Resources segments explores, develops, and produces oil and gas; produces and sells coal and uranium; operates geothermal power plants; and sale of electric power and steam. Idemitsu Kosan Co.,Ltd. was founded in 1911 and is headquartered in Tokyo, Japan.
Full IDKOF Calculator →Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.
Full MRK Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.